NS2389: Started Phase II trial

By WIR Staff | Feb 8, 1999 | 8:00 AM GMT

NeuroSearch A/S (CSE:NEUS), Glostrup, Denmark
Product: NS2389

Read the full 71 word article

How to gain access

Continue reading with a
two-week free trial.